Petri, M <br/><br/>
Hydroxychloroquine use in the Baltimore Lupus Cohort: effects on lipids, glucose and thrombosis.  [electronic resource] 

 -  Lupus  Jun 1996 
 - S16-22 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.; Review 
<br/><br/><label>ISSN: </label>0961-2033 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antirheumatic Agents--therapeutic use<br/>Baltimore<br/>Blood Glucose--metabolism<br/>Cohort Studies<br/>Diabetes Complications<br/>Diabetes Mellitus--drug therapy<br/>Female<br/>Humans<br/>Hydroxychloroquine--therapeutic use<br/>Hyperlipidemias--complications<br/>Lipids--blood<br/>Liver--physiopathology<br/>Lupus Erythematosus, Systemic--complications<br/>Male<br/>Thrombosis--complications